Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer risk takes shape

16.10.2001


About half of all patients with hereditary breast or ovarian cancer have mutations in a gene called BRCA1. Now the first images of the protein the gene encodes, BRCA1, are helping researchers work out how the mutations cause human disease.





The pictures reveal fine detail of how BRCA1 interacts with other proteins. Such information should help researchers work out how BRCA1 prevents cells becoming cancerous. They suspect that it is involved in DNA repair, controlling cell division and regulating gene activity.

Understanding BRCA1 should also make it easier to design genetic screening programmes to identify individuals at risk and catch cancer early. This is "very important to long-term survival," says Mark Glover of the University of Alberta in Edmonton, Canada, leader of one of the teams that have solved parts of BRCA1’s structure.


BRCA1 is a big protein — three times the size of haemoglobin, for example. Its chain of 1,863 amino acid links folds into a complex three-dimensional structure. Like a molecular Swiss Army knife, different parts are designed for different jobs.

Most of the mutations associated with breast and ovarian cancers beset the two regions composed of amino acids at the chain ends now under scrutiny. These areas vary least between different species, showing that their function is important enough for natural selection to stamp out slip-ups that would lead to variation.

The ends are probably the most important parts of the molecule, says Richard Baer, a cancer researcher at Columbia University in New York. "They won’t be the whole story, but they’re a big part of the story," he says.

Marked for death

One end of BRCA1 — the ’N’ terminus — bonds to another protein. The two form a catalyst that joins a small molecule called ubiquitin to other proteins. Ubiquitin tags proteins for destruction — an important stage in the body’s defence against cancer.

This much was already known. Rachel Klevit, of the University of Washington in Seattle, and colleagues have now visualized the interface between BRCA1 and its catalytic collaborator using nuclear magnetic resonance spectroscopy.

Klevit’s team was surprised to find that the collaborator joins to a different part of BRCA1 than they had suspected. The structure shows that mutations can disrupt either this junction or the ubiquitin-attachment machinery.

A full understanding of the N-terminal region’s workings might allow mutant BRCA1 proteins to be repaired, using small molecules to enhance or disrupt the protein machine, says Klevit. Unfortunately the many proteins that interact with BRCA1 make this a daunting task.

"We can do these sorts of things on the chalkboard, but until we’re clear on the multiple functions of all these different proteins it’s going to be difficult," says Klevit.

Pack up

Glover’s group focused on the other end of the molecule, the ’C’ terminus. Here, around 100 amino acids form structures known as BRCT repeats. These often feature in proteins that repair DNA — a vital part of tumour suppression.

X-ray crystallography reveals that the two BRCT repeats in BRCA1 "pack in a very intimate manner", says Glover. Mutations that alter the repeats disrupt their packing and unravel the protein. The loss of the last 11 amino acids at the protein’s C terminus is associated with aggressive, early-onset breast cancer.

The structures Klevit’s and Glover’s groups reveal are common to a range of proteins, but between them lies a large stretch of terra incognita, "that doesn’t look like any other protein", says Klevit. These amino acids — more than 1,500 of them — must do something, she says: "Nature’s not wasteful of its resources."


letters
Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

PETER S. BRZOVIC, PONNI RAJAGOPAL, DAVID W. HOYT, MARY-CLAIRE KING & RACHEL E. KLEVIT
Nature Structural Biology 8, 833-837 (October 2001)

letters
Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1

R. SCOTT WILLIAMS, RUTH GREEN & J.N. MARK GLOVER
Nature Structural Biology 8, 838-842 (October 2001)


JOHN WHITFIELD | Nature News Service
Further information:
http://www.nature.com/cancer/hotp/200110/4.html
http://www.nature.com/cancer/

More articles from Health and Medicine:

nachricht New approach for targeted cancer immunotherapy
30.07.2020 | Universität Basel

nachricht A new way to target cancers using 'synthetic lethality'
28.07.2020 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: TU Graz Researchers synthesize nanoparticles tailored for special applications

“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.

Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...

Im Focus: Tailored light inspired by nature

An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.

Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...

Im Focus: NYUAD astrophysicist investigates the possibility of life below the surface of Mars

  • A rover expected to explore below the surface of Mars in 2022 has the potential to provide more insights
  • The findings published in Scientific Reports, Springer Nature suggests the presence of traces of water on Mars, raising the question of the possibility of a life-supporting environment

Although no life has been detected on the Martian surface, a new study from astrophysicist and research scientist at the Center for Space Science at NYU Abu...

Im Focus: Manipulating non-magnetic atoms in a chromium halide enables tuning of magnetic properties

New approach creates synthetic layered magnets with unprecedented level of control over their magnetic properties

The magnetic properties of a chromium halide can be tuned by manipulating the non-magnetic atoms in the material, a team, led by Boston College researchers,...

Im Focus: A new method to significantly increase the range and stability of optical tweezers

Scientists of Tomsk Polytechnic University jointly with a team of the V.E. Zuev Institute of Atmospheric Optics of the Siberian Branch of the Russian Academy of Sciences have discovered a method to increase the operation range of optical traps also known

Optical tweezers are a device which uses a laser beam to move micron-sized objects such as living cells, proteins, and molecules. In 2018, the American...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“Conference on Laser Polishing – LaP 2020”: The final touches for surfaces

23.07.2020 | Event News

Conference radar for cybersecurity

21.07.2020 | Event News

Contact Tracing Apps against COVID-19: German National Academy Leopoldina hosts international virtual panel discussion

07.07.2020 | Event News

 
Latest News

Novel approach improves graphene-based supercapacitors

03.08.2020 | Information Technology

Germany-wide rainfall measurements by utilizing the mobile network

03.08.2020 | Information Technology

Drug discovery: First rational strategy to find molecular glue degraders

03.08.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>